Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
CDC’s website is being modified to comply with President Trump’s Executive Orders.
Volume 12, Number 10—October 2006
Letter

Leishmaniasis in Ancient Egypt and Upper Nubia

Albert R. Zink*†Comments to Author , Mark Spigelman‡§, Bettina Schraut*, Charles L. Greenblatt§, Andreas G. Nerlich*, and Helen D. Donoghue‡
Author affiliations: *Academic Teaching Hospital München-Bogenhausen, Munich, Germany; †Ludwig-Maximilians-Universität München, Munich, Germany; ‡University College London, London, UK; §The Hebrew University, Hadassah Medical School, Jerusalem, Israel

Main Article

Figure

PCR amplification of a 120-bp fragment of kinetoplastid mitochondrial DNA of Leishmania spp. in Egyptian and Nubian mummies. Lane 1, 50-bp ladder lanes 2–8, mummy samples; lanes 9,10, extraction controls; lane 11, PCR controls. Lane 6 provides a positive amplification product of the expected size.

Figure. PCR amplification of a 120-bp fragment of kinetoplastid mitochondrial DNA of Leishmania spp. in Egyptian and Nubian mummies. Lane 1, 50-bp ladder lanes 2–8, mummy samples; lanes 9,10, extraction controls; lane 11, PCR controls. Lane 6 provides a positive amplification product of the expected size.

Main Article

Page created: November 10, 2011
Page updated: November 10, 2011
Page reviewed: November 10, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external